Pathogenesis of fatty liver diseases and hepatocellular carcinoma

作     者：John Y.L.Chiang Tiangang Li John Y.L.Chiang;Tiangang Li

作者机构：Integrative Medical SciencesNortheast Ohio Medical UniversityRootstownOHUSA Harold Hamm Diabetes CenterDepartment of PhysiologyUniversity of Oklahoma Health Sciences CenterOklahoma CityOKUSA 

出 版 物：《Liver Research》 (肝脏研究（英文）)

年 卷 期：2022年第6卷第4期

页      面：201-202页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：This manuscript was supported by the USANational Institutes of Health(NIH)grants DK44442 and DK58379(J.Y.L.Chiang) 1R01DK131064 and 1R01 DK117965(T.Li) 

主　　题：diseases mechanism. liver 

摘      要：The prevalence of fatty liver diseases has increased rapidly in recent years to about 25%*** liver diseases are multi-faceted in pathogenesis,disease phenotype,and *** is important to understand disease pathogenesis and mechanism in order to develop effective and safe drug therapy for treating fatty liver *** fatty liver disease(AFLD,or alcohol associ-ated liver disease)and viral hepatitis have been the major causes of liver transplant,liver cancer,and death.